Hints and tips:
...Yet Pfizer’s $19bn in Paxlovid sales were almost a fifth of its 2022 total....
...Justice, intend to follow through on their mission to draw a tougher line on antitrust.Still outstanding are large contested deals, including Amgen’s planned $28bn takeover of Horizon Therapeutics and Pfizer...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Johnson, who on Sunday celebrated a daily record of 844,285 first and second vaccinations, fears a cross-Channel dispute could spark vaccine protectionism more widely across the globe....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...For example, the value of shares in video conferencing company Zoom had fallen 20 per cent following Pfizer’s vaccine announcement last week....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Any evidence that deep-pocketed nations are being favoured over poorer ones to receive consignments of one of the vaccines, or even a simple malfunctioning of manufacturing or distribution chains, could spark...
...therapy company Spark Therapeutics and Johnson & Johnson’s $3.4bn acquisition of surgical robotics specialist Auris Health....
...The LA-based company that built her, Brud media, recently closed an investment round led by Spark Capital that values it at $125m, according to TechCrunch....
...’s sale of its off-patent drug business to Mylan for $9.5bn; and Roche’s $4.8bn takeover of gene therapy company Spark Therapeutics....
...Shire’s haemophilia business also faces a potential threat from experimental gene therapies being developed by BioMarin, Spark Therapeutics and Pfizer, which are designed to fix the underlying genetic defect...
...Pfizer, for example, raised the price of 148 drugs, including Viagra, its erectile dysfunction treatment, and Lyrica, for nerve pain....
...A study comparing the price of 23 major cancer drugs in different countries could spark a debate when it is published at the conference, she says....
...They say that the recent market sell-off could spark a fresh wave of deals as acquisitive companies go bargain hunting....
...“There are two different perspectives on Pfizer,” said one minister. “One is that it will come in and strip out assets, the other is that they get the life sciences strategy....
...The UK company is concerned that the move could spark political controversy in the US. Back to top...
...However, the foreign acquisition of one of Britain’s biggest and most prized companies would be sure to rekindle debate over the openness of UK takeover rules and spark concern over jobs and investment in...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...(Financial Times) French ‘nuclear weapon’ against foreign takeovers sparks UK blast: As the UK government agonises over Pfizer’s bid for AstraZeneca, Arnaud Montebourg, France’s firebrand economy minister...
...(Bloomberg) “Pfizer Inc, the Indian unit of U.S. drug maker Pfizer Inc, is to take over local affiliate Wyeth Ltd, they said on Saturday after their boards approved the deal....
...Merck of the US tops the list with payments of $226m in 2012, followed by Eli Lilly with $219m and Pfizer with $162m....
...Republicans hate the idea of the government interfering in business, and Mr Jackson is apt to spark particular ire....
International Edition